Urogen Pharma Ltd
NASDAQ:URGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Urogen Pharma Ltd
NASDAQ:URGN
|
IL |
|
C
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
US |
|
R
|
Regions Financial Corp
XMUN:RN7
|
US |
|
Cogelec SA
PAR:ALLEC
|
FR |
|
E
|
Emak SpA
F:EK4
|
IT |
|
E
|
Excellence SA
WSE:EXC
|
PL |
|
F
|
Firefinch Ltd
F:N9F
|
AU |
Intrinsic Value
The intrinsic value for
Urogen Pharma Ltd (URGN) under the Base Case is hidden
USD.
Compared with the current market price of 45.05 USD, the stock appears hidden
.
Do our valuations actually work? See backtest results .
URGN looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether URGN usually does or if today's premium is unusual.
See where today’s valuation sits in URGN’s own history and what typically happened over the next 12 months after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Urogen Pharma Ltd.
Fundamental Analysis
Revenue & Expenses Breakdown
Urogen Pharma Ltd
Earnings Waterfall
Urogen Pharma Ltd
The intrinsic value for
Urogen Pharma Ltd (URGN) under the Base Case is hidden USD.
Compared with the current market price of 45.05 USD, the stock appears hidden.